Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | AGXT | P21549 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28175162 | 0.90 | ALDH1A1 (0.51) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL1968907 | 0.89 | IDO1 (0.47) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL31750770 | 0.88 | CYP1A2 (0.54) | L3MBTL1SLC6A2SLC6A3KMT2ALMNA | |
| SCHEMBL24790474 | 0.85 | ALDH1A1 (0.48) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL13180669 | 0.84 | MEN1 (0.46) | ALDH1A1CA2L3MBTL1SLC6A2KMT2A | |
| SCHEMBL29592808 | 0.83 | ALDH1A1 (0.49) | ALDH1A1LMNAOPRK1 | |
| SCHEMBL12387355 | 0.82 | PRSS1 (0.39) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL2221024 | 0.81 | IDO1 (0.44) | ALDH1A1KMT2AIDO1 | |
| SCHEMBL4963068 | 0.81 | IDO1 (0.44) | L3MBTL1KMT2ALMNAOPRK1IDO1 | |
| SCHEMBL6260611 | 0.81 | ALDH1A1 (0.40) | ALDH1A1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 881 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708838-B2 | Chemical sequestration of wellbore fluids in electric submersible pump systems | HALLIBURTON ENERGY SERVICES, INC. (US) | 2023-07-25 | — | — | US | claimed |
| EP-3634970-B1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | LAURUS LABS LTD (IN) | 2023-07-19 | — | — | EP | claimed |
| US-20220003240-A1 | CHEMICAL SEQUESTRATION OF WELLBORE FLUIDS IN ELECTRIC SUBMERSIBLE PUMP SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. | 2022-01-06 | — | — | US | claimed |
| WO-2022005484-A1 | CHEMICAL SEQUESTRATION OF WELLBORE FLUIDS IN ELECTRIC SUBMERSIBLE PUMP SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2022-01-06 | — | — | WO | claimed |
| US-11046676-B2 | Process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereof | LAURUS LABS LIMITED (IN) | 2021-06-29 | — | — | US | claimed |
| US-20200131163-A1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | LAURUS LABS LIMITED (IN) | 2020-04-30 | — | — | US | claimed |
| EP-3634970-A1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | Laurus Labs Limited (IN) | 2020-04-15 | — | — | EP | claimed |
| WO-2018224957-A1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | LAURUS LABS LIMITED (IN) | 2018-12-13 | — | — | WO | claimed |
| CN-105272852-A | Ezetimibe intermediate and preparation method | ZHEJIANG JIUZHOU PHARMACEUTICAL TECHNOLOGY CO LTD | 2016-01-27 | — | — | CN | claimed |
| US-20150177238-A1 | PROCESS FOR THE MANUFACTURING OF GLYCOCHIPS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-06-25 | — | — | US | claimed |
| WO-2008059307-A2 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | OM PHARMA (CH) | 2008-05-22 | — | — | WO | claimed |
| WO-2008059035-A2 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | OM PHARMA (CH) | 2008-05-22 | — | — | WO | claimed |
| US-7160517-B2 | Apparatus and methods for the automated synthesis of oligosaccharides | MASSACHUSETTS INSTITUTE OF TECHNOLGY (US) | 2007-01-09 | — | — | US | claimed |
| EP-1315559-B1 | APPARATUS AND METHODS FOR THE AUTOMATED SYNTHESIS OF OLIGOSACCHARIDES | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-03-22 | — | — | EP | claimed |
| EP-1315559-A2 | APPARATUS AND METHODS FOR THE AUTOMATED SYNTHESIS OF OLIGOSACCHARIDES | Massachusetts Institute Of Technology (US) | 2003-06-04 | — | — | EP | claimed |
| US-20020085964-A1 | Apparatus and methods for the automated synthesis of oligosaccharides | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2002-07-04 | — | — | US | claimed |
| WO-2002016384-A2 | APPARATUS AND METHODS FOR THE AUTOMATED SYNTHESIS OF OLIGOSACCHARIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-02-28 | — | — | WO | claimed |
| EP-0660835-A4 | PROCESS FOR PREPARING CERTAIN PYRROLO 3,4- -I(B))QUINOLINES, CERTAIN 1H-PYRANO 3',4':6,7)INDOLIZINO 1,2--I(B))QUINOLIN-3,14(4H,12H)-DIONES, AND CERTAIN 8-METHYL-7-(OXOPROPYL)-INDOLIZINO 1,2--I(B))QUINOLIN-9(11H)-ONES. | — | 1995-08-16 | — | — | EP | claimed |
| EP-0660835-A1 | PROCESS FOR PREPARING CERTAIN PYRROLO 3,4- $i(b)]QUINOLINES, CERTAIN 1H-PYRANO 3',4':6,7]INDOLIZINO 1,2-$i(b)]QUINOLIN-3,14(4H,12H)-DIONES, AND CERTAIN 8-METHYL-7-(OXOPROPYL)-INDOLIZINO 1,2-$i(b)]QUINOLIN-9(11H)-ONES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-07-05 | — | — | EP | claimed |
| WO-1994005672-A1 | PROCESS FOR PREPARING CERTAIN PYRROLO[3,4- b]QUINOLINES, CERTAIN 1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLIN-3,14(4H,12H)-DIONES, AND CERTAIN 8-METHYL-7-(OXOPROPYL)-INDOLIZINO[1,2-b]QUINOLIN-9(11H)-ONES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-03-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131163-A1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | SLC5A1, SLC5A2, DPP4 | ALDH1A1 2860/4885CA12 2194/4885CA1 3525/4885 |
| US-11046676-B2 | Process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereof | SLC5A2, SLC5A1, DPP4 | ALDH1A1 2460/4885CA12 1643/4885CA1 3045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.